Integrative molecular analysis of DNA methylation dynamics unveils molecules with prognostic potential in breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: BioMedInformatics (2023) 3:2, 434-445. https://doi.org/10.3390/biomedinformatics3020029
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2023
- Creator
-
Mehmood, Rashid
Alsaleh, Alanoud
Want, Muzamil Y.
Ahmad, Ijaz
Siraj, Sami
Ishtiaq, Muhammad
Alshehri, Faizah A.
Naseem, Muhammad
Yasuhara, Noriko
- DOI
-
10.3390/biomedinformatics3020029
- URN
-
urn:nbn:de:bvb:20-opus-321171
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:50 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mehmood, Rashid
- Alsaleh, Alanoud
- Want, Muzamil Y.
- Ahmad, Ijaz
- Siraj, Sami
- Ishtiaq, Muhammad
- Alshehri, Faizah A.
- Naseem, Muhammad
- Yasuhara, Noriko
- Universität Würzburg
Time of origin
- 2023
Other Objects (12)
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
Prognostic relevance of miRNA-155 methylation in anaplastic glioma
DNA methylation array analysis identifies breast cancer associated methylation changes in peripheral blood DNA
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
DNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia
Legumain expression as a prognostic factor in breast cancer patients
Investigation of global methylation and promoter methylation of two tumor suppressor genes in peripheral blood for breast cancer early detection
EP3 is an independent prognostic marker only for unifocal breast cancer cases
Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
Prognostic relevance of miRNA-155 methylation in anaplastic glioma
DNA methylation array analysis identifies breast cancer associated methylation changes in peripheral blood DNA
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
DNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia
Legumain expression as a prognostic factor in breast cancer patients
Investigation of global methylation and promoter methylation of two tumor suppressor genes in peripheral blood for breast cancer early detection
EP3 is an independent prognostic marker only for unifocal breast cancer cases
Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
Prognostic relevance of miRNA-155 methylation in anaplastic glioma
DNA methylation array analysis identifies breast cancer associated methylation changes in peripheral blood DNA
Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases
DNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia
Legumain expression as a prognostic factor in breast cancer patients
Investigation of global methylation and promoter methylation of two tumor suppressor genes in peripheral blood for breast cancer early detection
EP3 is an independent prognostic marker only for unifocal breast cancer cases
Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial